| 000 | 01309 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512005800.0 | ||
| 264 | 0 | _c19891011 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/0735-1097(89)90103-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFranciosa, J A | |
| 245 | 0 | 0 |
_aAcute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cSep 1989 |
||
| 300 |
_a624-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethyltyrosines _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aalpha-Methyltyrosine |
| 700 | 1 | _aSchwartz, D E | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 14 _gno. 3 _gp. 624-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0735-1097(89)90103-4 _zAvailable from publisher's website |
| 999 |
_c2576034 _d2576034 |
||